Patent details

Basic Information

Publication number:

EP4186502

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP231526146

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TASIMELTEON FOR USE FOR IMPROVING SLEEP

French Title of Invention:

TASIMELTÉON DESTINÉ À ÊTRE UTILISÉ POUR AMÉLIORER LE SOMMEIL

German Title of Invention:

TASIMELTEON ZUR VERWENDUNG ZUR VERBESSERUNG DES SCHLAFES

SPC Number:

Dates

Filing date:

13/02/2020

Grant date:

10/09/2025

EP Publication Date:

31/05/2023

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/09/2025

EP B1 Publication Date:

10/09/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

13/02/2040

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/09/2025

 

 

Name:

Vanda Pharmaceuticals Inc.

Address:

2200 Pennsylvania Ave NW Suite 300E, Washington, DC 20037, United States (US)

Inventor

1

Name:

SMIESZEK, Sandra

Address:

United States (US)

2

Name:

POLYMEROPOULOS, Mihael

Address:

United States (US)

Priority

Priority Number:

201962805057 P

Priority Date:

13/02/2019

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/343; A61P 25/20; C12Q 1/6883; A61P 43/00;

Publication

European Patent Bulletin

Issue number:

202537

Publication date:

10/09/2025

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/08/2026

Annual Fee Number:

7

Annual Fee Amount:

82 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages